´óÏóÊÓƵ

Acknowledgements
Introduction
Overview
About the Measure
     Target Measures
     Measure Reporting
     Guidelines for the Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents
Key Driver Diagrams
     Key Driver Diagrams for Target Measures
Quality Improvement Strategies
     Change Ideas to Improve Target Measure Performance
     Quality Improvement in Action: The NCINQ Antipsychotics in Children Learning Collaborative
Other Resources
     I. QI Best Practices for the Safe and Judicious Use of Antipsychotics in Children and Adolescents
     II. Guidelines and Recommendations for the Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents

Acknowledgements

The Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents toolkit is the product of collaboration among academic and research institutions, state and Federal agencies, and private sector stakeholders. Many individuals guided and contributed to the development of this toolkit. We are grateful for the time, knowledge, and expertise that they so generously shared.

This toolkit was developed by the National Collaborative for Improvement in Quality Measures (NCINQ), a consortium of organizations committed to advancing measurement of pediatric health care. NCINQ is led by the National Committee for Quality Assurance (NCQA) and funded by the ´óÏóÊÓƵ (AHRQ) and the Centers for Medicare & Medicaid Services (CMS) under the Pediatric Quality Measures Program (PQMP) website available at /pqmp/index.html. NCQA’s partners in this effort are New York University Langone Health and Youth MOVE National.

Sarah Hudson Scholle, MPH, DrPH (PI)
Sepheen Byron, MHS
Marleen Jones-Pool, MPH
Emily Morden, MSW
Serene Olin, PhD
Sweta Shah, MS
Cindy Van, MHSA
Laura Zwolinski, MPH
National Committee for Quality Assurance

Molly Finnerty, MD
Kimberly Hoagwood, PhD
Dara Weiss, MA
New York University

Kristin Thorp, MPP
Youth MOVE National

NCINQ would like to acknowledge and thank the participating health plans of the NCINQ Antipsychotics in Children Learning Collaborative for their involvement and input on this toolkit.

Empire Blue Cross Blue Shield HealthPlus
WellCare of NY, a Centene Company
EmblemHealthHealthfirst
Excellus BlueCross BlueShield

We also extend our gratitude to Kamila Mistry, Ph.D., AHRQ, U.S. Department of Health and Human Services (HHS), for her technical guidance and to the L&M Policy Research team for their support developing the toolkit.

This project was supported by grant number U18HS025296 from AHRQ. The toolkit was also funded under the AHRQ, HHS Contract Number: HHSA290201400003I;Task Number: 75Q80119F32002. The authors are solely responsible for this document’s contents, findings, and conclusions, which do not necessarily represent the views of AHRQ. Readers should not interpret any statement in this product as an official position of ´óÏóÊÓƵor of the U.S. Department of Health and Human Services. None of the authors has any affiliation or financial involvement that conflicts with the material presented in this product.

Public Availability Notice. This product is made publicly available by ´óÏóÊÓƵand may be used and reprinted without permission in the United States for noncommercial purposes, unless materials are clearly noted as copyrighted in the document. No one may reproduce copyrighted materials without the permission of the copyright holders. Users outside the United States must get permission from ´óÏóÊÓƵto reprint or translate this product. Anyone wanting to reproduce this product for sale must contact ´óÏóÊÓƵfor permission.